Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes
- PMID: 10878750
- DOI: 10.1016/s1043-2760(00)00272-1
Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes
Abstract
Tumor necrosis factor alpha (TNF-alpha) has well-described effects on lipid metabolism in the context of acute inflammation, as in sepsis. Recently, increased TNF-alpha production has been observed in adipose tissue derived from obese rodents or human subjects and TNF-alpha has been implicated as a causative factor in obesity-associated insulin resistance and the pathogenesis of type 2 diabetes. Thus, current evidence suggests that administration of exogenous TNF-alpha to animals can induce insulin resistance, whereas neutralization of TNF-alpha can improve insulin sensitivity. Importantly, results from knockout mice deficient in TNF-alpha or its receptors have suggested that TNF-alpha has a role in regulating in vivo insulin sensitivity. However, the absence of TNF-alpha action might only partially protect against obesity-induced insulin resistance in mice. Multiple mechanisms have been suggested to account for these metabolic effects of TNF-alpha. These include the downregulation of genes that are required for normal insulin action, direct effects on insulin signaling, induction of elevated free fatty acids via stimulation of lipolysis, and negative regulation of PPAR gamma, an important insulin-sensitizing nuclear receptor. Although current evidence suggests that neutralizing TNF-alpha in type 2 diabetic subjects is not sufficient to cause metabolic improvement, it is still probable that TNF-alpha is a contributing factor in common metabolic disturbances such as insulin resistance and dyslipidemia.
Similar articles
-
Mechanisms of TNF-alpha-induced insulin resistance.Exp Clin Endocrinol Diabetes. 1999;107(2):119-25. doi: 10.1055/s-0029-1212086. Exp Clin Endocrinol Diabetes. 1999. PMID: 10320052 Review.
-
An in vivo model for elucidation of the mechanism of tumor necrosis factor-alpha (TNF-alpha)-induced insulin resistance: evidence for differential regulation of insulin signaling by TNF-alpha.Endocrinology. 1998 Dec;139(12):4928-35. doi: 10.1210/endo.139.12.6336. Endocrinology. 1998. PMID: 9832430
-
Recent advances in the relationship between obesity, inflammation, and insulin resistance.Eur Cytokine Netw. 2006 Mar;17(1):4-12. Eur Cytokine Netw. 2006. PMID: 16613757 Review.
-
Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function.Nature. 1997 Oct 9;389(6651):610-4. doi: 10.1038/39335. Nature. 1997. PMID: 9335502
-
Tumor necrosis factor alpha: a key component of the obesity-diabetes link.Diabetes. 1994 Nov;43(11):1271-8. doi: 10.2337/diab.43.11.1271. Diabetes. 1994. PMID: 7926300 Review.
Cited by
-
Effect of Probiotic Soy Milk on Serum Levels of Adiponectin, Inflammatory Mediators, Lipid Profile, and Fasting Blood Glucose Among Patients with Type II Diabetes Mellitus.Probiotics Antimicrob Proteins. 2017 Mar;9(1):41-47. doi: 10.1007/s12602-016-9233-y. Probiotics Antimicrob Proteins. 2017. PMID: 27757829 Clinical Trial.
-
Enhanced insulin sensitivity in mice lacking ganglioside GM3.Proc Natl Acad Sci U S A. 2003 Mar 18;100(6):3445-9. doi: 10.1073/pnas.0635898100. Epub 2003 Mar 10. Proc Natl Acad Sci U S A. 2003. PMID: 12629211 Free PMC article.
-
Treatment update: thiazolidinediones in combination with metformin for the treatment of type 2 diabetes.Vasc Health Risk Manag. 2007;3(4):503-10. Vasc Health Risk Manag. 2007. PMID: 17969380 Free PMC article. Review.
-
Type 2 Diabetes and the Microbiome.J Endocr Soc. 2022 Nov 30;7(2):bvac184. doi: 10.1210/jendso/bvac184. eCollection 2022 Dec 15. J Endocr Soc. 2022. PMID: 36578879 Free PMC article. Review.
-
An extensive phenotypic characterization of the hTNFalpha transgenic mice.BMC Physiol. 2007 Dec 10;7:13. doi: 10.1186/1472-6793-7-13. BMC Physiol. 2007. PMID: 18070349 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
